Thus, ACE-inhibitors are effective and life-saving in an SSc renal crisis, establishing an important role of the renin-angiotensin system in the renal microvasculopathy in SSc; yet, these agents are ineffective in the treatment of SSc associated RP [29]. This evidence concerns the gene ACE and systemic sclerosis.